Guardant Health Inc

GHNASDAQ · USD
151.70USD0.00 (-2.05%)
2410

Guardant Health Inc (GH) Historical Volatility

GH's 30 day historical volatility is 57.33%, in the 58th percentile of readings over the past year. This is an average percentile, meaning Guardant Health Inc shares have moved roughly in line with their typical range. GH's 30 day implied volatility sits at 55.86%, with an IV Rank of 25.79%, leaving IV 1.47 points below historical volatility. This means options are pricing in less movement than the stock has actually delivered, as of Nov 13, 2026.

Read more

Tracking GH historical volatility helps you see how much Guardant Health Inc's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, GH's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor GH 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. GH's 30 day historical volatility, or GH HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing GH's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials.

Historical Volatility

HV Percentile
58thHV Percentile
Moderate

Historical movement is near its typical level for the past year. Neither unusually calm nor unusually active.

Historical Volatility (30d)57.33%

HV Percentile58th

Implied Volatility (30d)55.86%

IV Rank25.79%

IV Minus HV-1.47%

As of Nov 13, 2026

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of Nov 13, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of Nov 13, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →